课题基金 / 基金详情

Assessing prostate cancer aggressiveness using sodium MRI, multiparametric MRI, and PSMA-PET registered to Gleason-graded whole-mount histopathology

Assessing prostate cancer aggressiveness using sodium MRI, multiparametric MRI, and PSMA-PET registered to Gleason-graded whole-mount histopathology
使用钠 MRI、多参数 MRI 和注册到格里森分级整体组织病理学的 PSMA-PET 评估前列腺癌的侵袭性
批准号：
475895
负责人：
Tan Josephine
金额：
$7.65万
依托单位：
St-Joseph's Health Care London - St-Joseph Hospital
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475895&lang=en
关键词：
Gleason Grade Multiparametric Magnetic Resonance Imaging (Mpmri) Positron Emission Tomography (Pet) Prostate Cancer Prostate Specific Membrane Antigen (Psma) Sodium Magnetic Resonance Imaging (23na Mri)

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PCa) is the most common cancer among Canadian men. The aggressiveness of the cancer, which describes its likelihood to grow and spread, is based on tissue samples obtained on prostate biopsy. However, a standard prostate biopsy samples le
期刊论文(0)
专著(0)
科研奖励(0)
会议论文